HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of bis-di-octadecylamide of trehalose dicarboxylic acid (BDA.TDA) with glycolipid SL-IV as ELISA antigens for the serodiagnosis of leprosy.

Abstract
Two glycolipids--one synthetic and non-natural (BDA.TDA), the other natural and Mycobacterium tuberculosis species-specific (SL-IV)--were tested to determine their serological activity in sera obtained from leprosy patients, and to determine their discriminating ability in the detection of disease. The ELISA results obtained in the IgG antibody class show that both were useful substances capable of detecting multibacillary and paucibacillary disease in about 2 out of 3 leprosy patients. When these antigens were tested in parallel, the sensitivity of the ELISA test was increased by 10% without a decrease in specificity.
AuthorsA Laszlo, P Cruaud, M B Goren, V Handzel, F Papa, H L David
JournalInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (Int J Lepr Other Mycobact Dis) Vol. 60 Issue 3 Pg. 376-81 (Sep 1992) ISSN: 0148-916X [Print] United States
PMID1282141 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Epitopes
  • Glycolipids
  • Immunoglobulin G
  • Immunoglobulin M
  • sulfoglycolipids
  • trehalose dicarboxylic acid bis-(N,N-dioctadecylamide)
Topics
  • Antibodies, Bacterial (immunology)
  • Antigens, Bacterial (immunology)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Epitopes (immunology)
  • False Negative Reactions
  • Glycolipids (immunology)
  • Humans
  • Immunoglobulin G (immunology)
  • Immunoglobulin M (immunology)
  • Leprosy (immunology)
  • Mycobacterium tuberculosis (chemistry, immunology)
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Serologic Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: